Study Shows Older Lung Recipients Can Achieve Outcomes Comparable to Younger Patients

That headline from News-Medical today—about older lung transplant recipients achieving outcomes comparable to younger patients—landed like a quiet revelation for anyone who’s watched a parent or neighbor wrestle with COPD or pulmonary fibrosis. It’s not just medical optimism; it’s a tangible shift in what’s possible, especially here in Chicago, where the lung transplant programs at Northwestern Memorial and the University of Chicago Medicine have been quietly refining their approach for years. You don’t require to be a cardiothoracic surgeon to observe how this changes the conversation: age alone shouldn’t sideline someone from a chance at easier breathing.

The source material points to a single-institution study of 1,025 patients showing short-term outcomes in older groups were comparable or even superior to younger cohorts. Digging into the verified research, we see this isn’t isolated. A 2000–2013 analysis cited in PMC10693648 found that while long-term survival for recipients over 70 still lags, short-term results have improved significantly and now mirror those of younger patients. Meanwhile, the Journal of Thoracic and Cardiovascular Surgery study from August 2025—covering over 33,000 transplants from 2006 to 2023—revealed a telling pattern: as recipients aged, single lung transplants became far more common. For those 75 to 79, three in four received a single lung, versus less than one in five for the youngest group. Yet, in that oldest bracket, median survival showed almost no difference between single and bilateral transplants—4.0 versus 3.9 years—a detail that suggests surgeons are increasingly tailoring the procedure to individual physiology, not just age.

Here in Chicago, that nuance plays out in real time. At Northwestern’s Bluhm Cardiovascular Institute, teams have been tracking how comorbidities like prior cardiac surgery—which the JTCVS study linked to a 27% higher mortality risk—affect listing decisions. Over near the South Loop, UChicago Medicine’s transplant coordinators routinely consult with geriatric specialists to assess frailty, not just FEV1 scores, when evaluating elders for referral. It’s a shift from chronological age to physiological age, and it’s gaining traction because the data supports it. The city’s high volume of complex cases—driven by both its industrial legacy and its role as a Midwest referral hub—means its programs see a broad spectrum of older candidates, from former steelworkers in South Chicago to retirees in Evanston managing alpha-1 antitrypsin deficiency.

This isn’t just about surgical technique. It’s about resource allocation and honest conversations. When a 72-year-old from Oak Park is evaluated, the question isn’t just “Can they survive the operation?” but “What does recovery look like for them?” The JTCVS data shows older patients are more likely to get a single lung transplant—a procedure that, while offering less long-term survival than bilateral in younger groups, may offer a better quality-of-life trade-off when bilateral poses prohibitive risk. In Chicago, where access to rehab facilities like Shirley Ryan AbilityLab or home health networks through VNA of Chicagoland can make or break postoperative success, that calculus becomes deeply local. A patient’s proximity to support, their caregiver network, even their ability to navigate the CTA for follow-up—all these factor into whether transplant is a viable path.

And let’s not overlook the psychosocial layer. The PMC study hinted at improved short-term survival over time, which likely reflects better patient selection and postoperative management—not just newer immunosuppressants. In a city with strong community anchors like the Respiratory Health Association (based in the West Loop) or patient advocacy groups affiliated with the American Lung Association’s Illinois chapter, older candidates often report feeling more heard now than a decade ago. Teams aren’t just asking if lungs are available; they’re asking if the *timing* is right for *this* person, with *this* history, in *this* neighborhood.

Given my background in public health policy, if this trend impacts you or someone you love in Chicago, here are the three types of local professionals you need to know about—not as endorsements, but as archetypes to guide your search:

Transplant pulmonologists with geriatric training: Look for physicians who split time between pulmonary critical care and geriatrics, or who explicitly co-manage cases with specialists from institutions like the Rush University Medical Center’s Aging Program. They’ll weigh lung function against cognitive reserve, fall risk, and medication burden—not just spirometry.
Cardiothoracic surgeons experienced in single-lung techniques for older recipients: Seek out surgeons at high-volume centers (like those at Northwestern or UChicago) who publish outcomes specifically for the 65+ cohort and discuss their approach to minimizing ischemia time or managing frailty during surgery. Ask about their rates of primary graft dysfunction in older patients.
Transplant coordinators specializing in senior logistics: These aren’t just schedulers—they’re advocates who understand how to navigate Medicare Part B coverage for immunosuppressants, coordinate with home health agencies familiar with post-sternotomy precautions (like those serving the North Shore), and connect patients to peer support networks, such as the lung transplant forums hosted monthly at the Harold Washington Library.

Ready to find trusted professionals? Browse our complete directory of top-rated lung transplant specialists in the Chicago IL area today.